Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cencora Inc shares valued at $293,200 were purchased by Lon Greenberg on Jun 18 ’25. At $293.20 per share, Lon Greenberg acquired 1,000 shares.
Also, Battaglia Silvana purchased 4,077 shares, netting a total of over 1,212,520 in proceeds.
Before that, Mauch Robert P. had added 4,969 shares to its account. In a trade valued at $1,467,346, the Officer bought Cencora Inc shares for $295.30 each.
As published in a research note from Wells Fargo on June 03, 2025, Cencora Inc [COR] has been rated up from an Equal weight to an Overweight and the price target has been revised to $337. As of September 18, 2024, BofA Securities has decreased its “Buy” rating to a “Neutral” for COR. Earlier on February 26, 2024, Leerink Partners initiated its rating. Their recommendation was “an Outperform” for COR stock.
Analyzing COR Stock Performance
On last trading session,, Cencora Inc [NYSE: COR] rose 1.21% to $296.75. During the last five days, there has been a surge of approximately 3.53%. Over the course of the year, Cencora Inc shares have jumped approximately 32.08%. Shares of the company reached a 52-week high of $309.35 on 05/07/25 and a 52-week low of $223.92 on 01/02/25.
Support And Resistance Levels for Cencora Inc (COR)
According to the 24-hour chart, there is a support level at 293.58, which, if violated, would cause prices to drop to 290.41. In the upper region, resistance lies at 299.03. The next price resistance is at 301.31. RSI (Relative Strength Index) is 60.48 on the 14-day chart, showing neutral technical sentiment.
Which companies own the most shares of Cencora Inc (COR)?
In terms of Cencora Inc share price expectations, FactSet research, analysts set an average price target of 288 in the next 12 months, down nearly -1.77% from the previous closing price of $293.20. Analysts anticipate Cencora Inc stock to reach 288 by 2025, with the lowest price target being 288. In spite of this, 18 analysts ranked Cencora Inc stock as Buy at the end of 2025. On January 03, 2024, Barclays assigned a price target of “an Overweight” to the stock and initiated coverage with a $242.
